iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer

NCT03867799 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Nivolumab

Sponsor

Royal Marsden NHS Foundation Trust